Protect Pharmaceutical Stock Net Income
| PRTT Stock | USD 0.08 0.00 0.00% |
As of the 3rd of February, Protect Pharmaceutical holds the Semi Deviation of 15.72, coefficient of variation of 1491.58, and Risk Adjusted Performance of 0.0588. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Protect Pharmaceutical, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from Protect Pharmaceutical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Protect Pharmaceutical's valuation are summarized below:Protect Pharmaceutical does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Protect |
Protect Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Protect Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Protect Pharmaceutical.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Protect Pharmaceutical on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Protect Pharmaceutical or generate 0.0% return on investment in Protect Pharmaceutical over 90 days. Protect Pharmaceutical is related to or competes with Hallmark Venture, Questor Technology, Avante Logixx, Crown Equity, Tel-Instrument Electronics, and Environmmtl Tectonic. Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses More
Protect Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Protect Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Protect Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 32.19 | |||
| Information Ratio | 0.0646 | |||
| Maximum Drawdown | 139.55 | |||
| Value At Risk | (29.40) | |||
| Potential Upside | 48.39 |
Protect Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Protect Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Protect Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Protect Pharmaceutical historical prices to predict the future Protect Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0588 | |||
| Jensen Alpha | 1.59 | |||
| Total Risk Alpha | 0.0945 | |||
| Sortino Ratio | 0.0453 | |||
| Treynor Ratio | (0.79) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Protect Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Protect Pharmaceutical February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0588 | |||
| Market Risk Adjusted Performance | (0.78) | |||
| Mean Deviation | 11.76 | |||
| Semi Deviation | 15.72 | |||
| Downside Deviation | 32.19 | |||
| Coefficient Of Variation | 1491.58 | |||
| Standard Deviation | 22.6 | |||
| Variance | 510.92 | |||
| Information Ratio | 0.0646 | |||
| Jensen Alpha | 1.59 | |||
| Total Risk Alpha | 0.0945 | |||
| Sortino Ratio | 0.0453 | |||
| Treynor Ratio | (0.79) | |||
| Maximum Drawdown | 139.55 | |||
| Value At Risk | (29.40) | |||
| Potential Upside | 48.39 | |||
| Downside Variance | 1036.44 | |||
| Semi Variance | 247.2 | |||
| Expected Short fall | (27.39) | |||
| Skewness | 0.5781 | |||
| Kurtosis | 4.85 |
Protect Pharmaceutical Backtested Returns
Protect Pharmaceutical is out of control given 3 months investment horizon. Protect Pharmaceutical maintains Sharpe Ratio (i.e., Efficiency) of 0.0719, which implies the firm had a 0.0719 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-five different technical indicators, which can help you to evaluate if expected returns of 1.68% are justified by taking the suggested risk. Use Protect Pharmaceutical Coefficient Of Variation of 1491.58, risk adjusted performance of 0.0588, and Semi Deviation of 15.72 to evaluate company specific risk that cannot be diversified away. Protect Pharmaceutical holds a performance score of 5 on a scale of zero to a hundred. The company holds a Beta of -1.91, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Protect Pharmaceutical are expected to decrease by larger amounts. On the other hand, during market turmoil, Protect Pharmaceutical is expected to outperform it. Use Protect Pharmaceutical jensen alpha, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to analyze future returns on Protect Pharmaceutical.
Auto-correlation | -0.37 |
Poor reverse predictability
Protect Pharmaceutical has poor reverse predictability. Overlapping area represents the amount of predictability between Protect Pharmaceutical time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Protect Pharmaceutical price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Protect Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | -0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Protect Pharmaceutical reported net income of (122,611). This is 100.05% lower than that of the Pharmaceuticals sector and 100.43% lower than that of the Health Care industry. The net income for all United States stocks is 100.02% higher than that of the company.
Protect Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Protect Pharmaceutical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Protect Pharmaceutical could also be used in its relative valuation, which is a method of valuing Protect Pharmaceutical by comparing valuation metrics of similar companies.Protect Pharmaceutical is currently under evaluation in net income category among its peers.
Protect Fundamentals
| Current Valuation | 2.6 M | |||
| Shares Outstanding | 1.11 M | |||
| Shares Owned By Insiders | 84.30 % | |||
| Price To Earning | (23.96) X | |||
| EBITDA | (115.4 K) | |||
| Net Income | (122.61 K) | |||
| Cash And Equivalents | 20.07 K | |||
| Total Debt | 101 K | |||
| Current Ratio | 0.40 X | |||
| Book Value Per Share | (0.01) X | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 11 | |||
| Beta | 2.38 | |||
| Market Capitalization | 2.5 M | |||
| Retained Earnings | (9.37 M) | |||
| Working Capital | (33 K) | |||
| Current Liabilities | 33 K | |||
| Z Score | 14.4 |
About Protect Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Protect Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protect Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protect Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Protect Pink Sheet Analysis
When running Protect Pharmaceutical's price analysis, check to measure Protect Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protect Pharmaceutical is operating at the current time. Most of Protect Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Protect Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protect Pharmaceutical's price. Additionally, you may evaluate how the addition of Protect Pharmaceutical to your portfolios can decrease your overall portfolio volatility.